This study revealed that LRG1 level gradually decreased from baseline to week 12 in RA patients who underwent biologics treatment, which could be explained by the anti-inflammatory effect of biologics on the level of LRG1 (an inflammatory marker) [35–37]. This evidence concerns the gene LRG1 and rheumatoid arthritis.